PRKN and Parkinson disease: For example, we previously identified ZNF746/PARIS as a parkin-interacting substrate that suppresses mitochondrial biogenesis in dopaminergic neurons (DA), thus leading to DA degeneration in Parkinson’s disease (PD) pathogenesis4,5.